Global Ventral Hernia Treatment Market Insights Forecasts to 2032

• The Global Ventral Hernia Treatment Market Size was valued at USD 4.7 Billion in 2022.
• The Market is growing at a CAGR of 6.9% from 2022 to 2032.
• The Worldwide Ventral Hernia Treatment Market size is expected to reach USD 9.2 Billion by 2032.
• Europe is expected to grow the fastest during the forecast period.

Get more details on this report -

Request Free Sample PDF

The Global Ventral Hernia Treatment Market Size is expected to reach USD 9.2 Billion by 2032, at a CAGR of 6.9% during the forecast period 2022 to 2032.

 

Market Overview

A ventral hernia occurs when a portion of the intestines or other abdominal tissue pushes through a weak spot in the abdominal muscles, generating a bulge or protrusion on the skin's surface. Ventral hernias of the abdomen are non-inguinal, non-hiatal abnormalities in the fascia of the abdominal wall. They are commonly seen in clinical practice. General surgeons frequently perform surgery to address these abdominal wall abnormalities. This activity explains the pathogenesis, examination, and therapy of ventral hernias and emphasizes the importance of the interprofessional team in caring for impacted patients. A ventral hernia occurs when a portion of the intestines or other abdominal tissue pushes through a weak spot in the abdominal muscles, generating a bulge or protrusion on the skin's surface. Medical devices, surgical equipment, medications, and other relevant items and services used in the diagnosis, treatment, and management of ventral hernias comprise the ventral hernia treatment market.

 

Report Coverage

This research report categorizes the global ventral hernia treatment market based on various segments and regions and forecasts revenue growth and analyses trends in each submarket. The report analyses the key growth drivers, opportunities, and challenges influencing the global ventral hernia treatment market. Recent market developments and competitive strategies such as expansion, product launch, and development, partnership, merger, and acquisition have been included to draw the competitive landscape in the market. The report strategically identifies and profiles the key market players and analyses their core competencies in each sub-segment of the global ventral hernia treatment market. Technological innovation and advancement will further optimize the performance of the product, enabling it to acquire a wider range of applications in the downstream market.

 

 

Driving Factors

Obesity, an aging population, and a lack of physical activity all contribute to an increase in the prevalence of ventral hernias worldwide. This has increased demand for hernia repair surgeries, as well as related products and services. Also, the advancement of advanced hernia repairs technologies such as mesh implants, surgical staplers, and robotic-assisted surgical systems has increased the efficiency and safety of hernia repair surgeries, resulting in greater acceptance of these devices. Moreover, Healthcare organizations and governments have employed awareness and education efforts to raise public awareness about ventral hernias and their treatment options, resulting in increased demand for hernia repair surgery and related products and services. In addition, globally rising spending on healthcare, particularly in emerging nations, has boosted access to healthcare treatments such as hernia repair surgeries and related products and services.

 

Restraining Factors

Ventral Hernia operations and related products and services can be expensive, especially for uninsured or underinsured people, limiting access to care. Some nations reimbursement systems for ventral hernia treatment may be insufficient, limiting access to care and influencing demand for ventral hernia treatment and related products and services. The ventral hernia treatment market is highly competitive, with multiple major players present, making it difficult for new entrants to establish themselves and compete with established businesses.

 

 Market Segmentation

• In 2022, the incisional hernia segment is dominating the market with the largest market share during the forecast period.

The global ventral hernia treatment market is classified into Epigastric {stomach area} hernia, Umbilical {belly button} hernia, & Incisional hernia, based on the types. Among these types, an incisional hernia is currently the dominant segment in the global ventral hernia treatment market. An incisional hernia occurs as a complication of a prior abdominal surgery, where the incision site becomes weak and allows the abdominal contents to protrude through the abdominal wall. The rising number of abdominal surgeries and the increasing prevalence of obesity, which is a risk factor for ventral hernia, are some of the key factors driving the growth of the incisional hernia treatment market.

 

• In 2022, the open hernia surgery segment is influencing the largest market share over the forecast period.

Based on the surgery, the global ventral hernia treatment market is segmented into open hernia surgery, laparoscopic surgery, and robotic hernia surgery. Throughout these segments, the open hernia surgery segment will hold the greatest market share owing to open hernia surgery being the traditional method of treating ventral hernia, which involves making a large incision in the abdomen to access the hernia and repair it.

 

However, in recent years, there has been a movement toward minimally invasive methods such as laparoscopic and robotic surgery due to their advantages over open surgery, such as reduced postoperative pain, faster recovery, and a lower chance of complications.

 

• In 2022, the hospital segment is driving market share growth during the forecast period.

On the basis of end users, the global ventral hernia treatment market is segmented into hospitals, ambulatory surgical centers, and clinics. Among these, hospital pharmacies are expected to grow the market during the forecast period, owing to Hospitals having a team of professional medical personnel, such as surgeons, anesthesiologists, and nurses, who are trained and skilled in the treatment of ventral hernias. These healthcare providers have the skills and expertise required to deliver efficient hernia therapy and manage any issues that may emerge during or after the procedure. Moreover, hospitals are provided with the modern technology and equipment required to perform hernia surgery safely and effectively. This comprises surgical equipment, imaging technology, and monitoring gadgets that aid in the safety and well-being of the patient during the surgery.

 

Regional Segment Analysis of the ventral hernia treatment market

• North America (U.S., Canada, Mexico) 
• Europe (Germany, France, U.K., Italy, Spain, Rest of Europe)
• Asia-Pacific (China, Japan, India, Rest of APAC)
• South America (Brazil and the Rest of South America) 
• The Middle East and Africa (UAE, South Africa, Rest of MEA)

 

North America is holding the market with the largest market share over the forecast period

 

Get more details on this report -

Request Free Sample PDF

 

The market for ventral hernia therapy in north america is a significant business sector within the worldwide hernia treatment market owing to the rising prevalence of obesity and geriatric population in North America has contributed to the region's rising incidence of ventral hernias. This, in turn, has increased demand for hernia repair surgeries and related products and services. The market is also seeing an increasing demand for minimally invasive surgical methods, such as laparoscopic surgery, over traditional open surgeries. The benefits of minimally invasive procedures, such as less discomfort, faster recovery, and shorter hospital stays, are driving this trend.

 

Europe is expected to register significant revenue growth during the forecast period, due to there is increased awareness and education about hernias and their treatment choices among healthcare practitioners and the general public, which is boosting demand for hernia repair goods and services. Also, many European countries have favorable reimbursement policies for hernia repair surgeries, which is driving growth in the ventral hernia treatment market.

 

Competitive Analysis

The report offers the appropriate analysis of the key organizations/companies involved within the global ventral hernia treatment market along with a comparative evaluation primarily based on their product offering, business overviews, geographic presence, enterprise strategies, segment market share, and SWOT analysis. The report also provides an elaborative analysis focusing on the current news and developments of the companies, which includes product development, innovations, joint ventures, partnerships, mergers & acquisitions, strategic alliances, and others. This allows for the evaluation of the overall competition within the market.

 

List of Key Companies

• Medtronic
• Becton Dickinson & Company
• Braun Melsungen AG
• Cook Medical Inc.
• Cooper Companies Inc.
• Baxter International, Inc.
• Integra LifeSciences
• W.L. Gore & Associates
• AbbVie
• Johnson & Johnson Services, Inc.

 

Key Target Audience

• Market Players
• Investors
• End-users
• Government Authorities 
• Consulting And Research Firm
• Venture capitalists
• Value-Added Resellers (VARs)

 

Recent Development

• In June 2021, Becton Dickinson & Company offers support and education to individuals having hernia repair surgery. This includes tools and information about the treatment, as well as suggestions for managing to heal and prevent recurring hernias.

 

Market Segment

This study forecasts revenue at global, regional, and country levels from 2022 to 2032. Spherical Insights has segmented the Global Ventral Hernia Treatment Market based on the below-mentioned segments:

 

Global Ventral Hernia Treatment Market, By Type

• Epigastric {stomach area} hernia
• Umbilical {belly button} hernia
• Incisional hernia

 

Global Ventral Hernia Treatment Market, By Surgery

• Open hernia surgery
• Laparoscopic surgery
• Robotic hernia surgery

 

Global Ventral Hernia Treatment Market, By End Users

• Hospitals
• Ambulatory Surgical Centres
• Clinics

 

Ventral Hernia Treatment Market, By Regional Analysis

• North America
  • US
  • Canada
  • Mexico

• Europe
  • Germany
  • Uk
  • France
  • Italy
  • Spain
  • Russia
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Rest of Asia Pacific
• South America
  • Brazil
  • Argentina
  • Rest of South America
• Middle East & Africa
  • UAE
  • Saudi Arabia
  • Qatar
  • South Africa
  • Rest of Middle East & Africa